Nurix Therapeutics (NRIX) director gets 31,250 stock options at $15.86
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Nurix Therapeutics, Inc. reported a Form 4 showing director Roger D. Dansey received a grant of stock options for 31,250 shares of common stock at an exercise price of $15.86 per share. The option vests 100% on the earlier of the next annual stockholder meeting or May 15, 2027, subject to continued service, and expires on May 14, 2036. This is a compensation-related award, not an open-market trade.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
DANSEY ROGER D
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (right to buy) | 31,250 | $0.00 | -- |
Holdings After Transaction:
Director Stock Option (right to buy) — 31,250 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 31,250 options
Exercise price: $15.86 per share
Underlying shares: 31,250 shares
+2 more
5 metrics
Option grant size
31,250 options
Director stock option award
Exercise price
$15.86 per share
Director stock option strike price
Underlying shares
31,250 shares
Common stock underlying the option
Shares after transaction
31,250 derivative securities
Total options held after this grant
Option expiration
May 14, 2036
Director option expiry date
Key Terms
Director Stock Option (right to buy), exercise price, expiration date, vests as to 100% of the award, +1 more
5 terms
Director Stock Option (right to buy) financial
"security_title: Director Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 15.8600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-14T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vests as to 100% of the award financial
"The stock option vests as to 100% of the award on the earlier"
annual meeting of the Issuer's stockholders financial
"on the earlier of (a) the date of the next annual meeting"
FAQ
What insider transaction did Nurix Therapeutics (NRIX) disclose for Roger D. Dansey?
Nurix disclosed a compensation-related grant of stock options to director Roger D. Dansey. He received options for 31,250 shares of common stock, recorded at a price of $0.00, reflecting an award rather than a market purchase.
What is the exercise price of Roger Dansey’s Nurix (NRIX) stock options?
The options have an exercise price of $15.86 per share. This means Dansey can buy Nurix common stock at $15.86 if he chooses to exercise the option after it vests and before expiration.
When do Roger Dansey’s Nurix Therapeutics (NRIX) stock options vest?
The option vests as to 100% of the award on the earlier of the next annual meeting of stockholders or May 15, 2027. Vesting requires that Dansey remains in service to Nurix on the applicable vesting date.
When do Roger Dansey’s Nurix (NRIX) stock options expire?
The stock options expire on May 14, 2036. After this expiration date, Dansey can no longer exercise the option to purchase Nurix common shares at the $15.86 exercise price.